Endocrine Therapy Omission in Estrogen Receptor-Low (1-10%) Early Stage Breast Cancer: An Updated Analysis of the NCDB Database.
Medicine
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.